Which disease is associated with a propagative cycle?
The study of human diseases and their impact on society is known as?
According to WHO guidelines, what prevalence of Bitot's spots indicates a public health problem?
What is the most common cancer diagnosed in men?
What is the best indicator of the availability, utilization, and effectiveness of health services?
Which method is primarily used to assess HIV prevalence?
All of the following are characteristics of case control study except:
Which study design is considered the most effective for establishing a definitive causal relationship in epidemiological research?
What is the structure of the ICD-10 classification system?
Interval between the primary and secondary case is called?
Explanation: ***Filaria*** - The **filarial worm** undergoes a **biological transmission cycle** in the mosquito vector where microfilariae develop through larval stages (L1 → L2 → L3) with multiplication. - This represents a **cyclopropagative cycle** (both development and multiplication occur in the vector). - In the context of this question and classical teaching, filaria is considered the standard example of biological transmission with vector multiplication. - The infective L3 larvae multiply from a single microfilaria, and multiple larvae can develop within one mosquito. *Plague* - **Plague** (*Yersinia pestis*) is transmitted by fleas through **mechanical transmission**. - Bacteria multiply in the flea's gut causing blockage (blocking transmission), but this is not considered a true biological cycle. - The pathogen does not undergo developmental stages in the vector. *Malaria* - **Malaria** (*Plasmodium* spp.) undergoes the **sporogonic cycle** in the mosquito, which is also a **cyclopropagative cycle**. - Gametocytes → ookinete → oocyst → sporozoites (development with multiplication). - While biologically similar to filaria, in classical epidemiology teaching, filaria is more commonly cited as the example for propagative transmission. *None of the options* - This option is incorrect as filaria demonstrates biological transmission with multiplication in the vector. - Both filaria and malaria technically undergo cyclopropagative cycles, but filaria is the conventional answer in medical education contexts.
Explanation: ***Epidemiology*** - **Epidemiology** is defined as the study of the distribution, determinants, patterns, and frequency of health and disease conditions in defined populations, including their **impact on society**. - It is the fundamental science of **public health** that specifically studies how diseases affect populations and society through systematic investigation using statistical and analytical methods. - Epidemiological studies directly examine disease burden, mortality, morbidity, and societal impact, making it the most precise answer for studying diseases and their societal consequences. - Key epidemiological measures (incidence, prevalence, DALYs) quantify the **societal impact** of diseases. *Public health* - **Public health** is the broader applied field that uses epidemiological findings to implement programs, policies, and interventions. - While public health addresses disease impact, it is primarily an **action-oriented discipline** focused on prevention and health promotion, not just the study of diseases. - Public health encompasses multiple disciplines including epidemiology, health education, environmental health, and health policy. *Health sociology* - **Health sociology** (or medical sociology) examines social factors, behaviors, and structures that influence health outcomes and healthcare access. - It focuses on social determinants, health inequalities, and illness behavior from a **sociological perspective**, rather than the scientific study of disease distribution and patterns. *Medical anthropology* - **Medical anthropology** studies health, illness, and healing through a **cultural and ethnographic lens**. - It examines how different cultures understand disease, healing practices, and medical systems, rather than studying disease patterns and their population-level impact.
Explanation: ***≥ 0.5% prevalence*** - According to **WHO guidelines**, a prevalence of Bitot's spots of **≥ 0.5%** (greater than or equal to 0.5%) in children aged 6-71 months indicates a **moderate public health problem** related to **vitamin A deficiency**. - This threshold is used for **programmatic decision-making** and intervention strategies to combat **xerophthalmia** (vitamin A deficiency eye disease). - At **≥ 1.0%** prevalence, it indicates a **severe public health problem**. *> 1% prevalence* - While ≥ 1% prevalence indicates a **severe public health problem**, the **initial WHO threshold** for identifying a public health problem due to **vitamin A deficiency** as indicated by Bitot's spots is **≥ 0.5%**. - This allows for **earlier public health action** before the situation becomes severe. *> 2% prevalence* - A prevalence of 2% implies a **critical vitamin A deficiency situation**, far exceeding the **WHO's diagnostic threshold** for initiating public health interventions. - Interventions would be critically urgent at this level, but the criteria for recognizing a problem are met at **≥ 0.5%**. *None of the options* - This option is incorrect because the **WHO has specific guidelines** for the prevalence of **Bitot's spots** that indicate a public health problem. - The correct threshold of **≥ 0.5%** is provided among the choices, which is the established criterion for a **moderate public health problem**.
Explanation: ***Oral cancer*** - **Oral cancer** is the most common cancer diagnosed in men in India, particularly cancers of the **lip, oral cavity, and oropharynx**. - India accounts for approximately **one-third of the global burden** of oral cancers. - Major risk factors include **tobacco chewing (gutka, pan masala, betel quid), smoking, and alcohol consumption**. - Early detection through **oral examination** and avoiding tobacco products are key preventive measures. *Prostate cancer* - While prostate cancer is the most common cancer in men in **Western populations**, it ranks **much lower in India** (typically 3rd-5th most common). - Incidence is increasing in urban Indian populations due to improved detection and lifestyle changes. *Bladder cancer* - **Bladder cancer** is significant but less common than oral cancer in Indian men. - Risk factors include **smoking** and occupational exposure to chemicals. *Colorectal cancer* - **Colorectal cancer** is increasing in incidence in India but remains less common than oral cancer in men. - Screening with **colonoscopy** is recommended for early detection, especially in those with family history.
Explanation: ***IMR*** - The **Infant Mortality Rate (IMR)** is widely considered the best single indicator of the availability, utilization, and effectiveness of health services because it reflects the health status of a population and the quality of prenatal, perinatal, and postnatal care. - A lower IMR generally indicates better access to maternal and child healthcare, nutrition, sanitation, and overall societal development. *MMR* - The **Maternal Mortality Ratio (MMR)** reflects the risk of maternal death relative to the number of live births and is a measure of the quality of maternal healthcare services. - While important, MMR focuses specifically on maternal health outcomes and does not encompass the broader availability and effectiveness of health services for all age groups as comprehensively as IMR. *Hospital bed OCR* - **Hospital bed occupancy rate (OCR)** indicates the proportion of available hospital beds that are occupied over a given period, reflecting the utilization of hospital resources. - While it offers insight into hospital efficiency and demand, it does not directly reflect the overall availability, effectiveness, or quality of primary care, preventive services, or broader public health interventions. *DALY* - **Disability-Adjusted Life Years (DALY)** measure the total number of healthy life years lost due to premature mortality and disability from disease or injury. - DALYs provide a comprehensive measure of disease burden but are more focused on quantifying the impact of diseases and injuries on health than on directly assessing the availability, utilization, and effectiveness of health services themselves.
Explanation: ***Sentinel surveillance in high-risk populations*** - **Sentinel surveillance** focuses on specific, well-defined groups, such as pregnant women or individuals attending STD clinics, to get a representative estimate of **HIV prevalence** in the broader community. - This method is particularly effective for diseases that are difficult to track through general population surveys due to stigma or low overall prevalence. *Passive surveillance through reporting systems* - **Passive surveillance** relies on healthcare providers voluntarily reporting cases, which often leads to **underreporting** and an incomplete picture of an epidemic's true scope. - It primarily captures known cases rather than estimating the overall **prevalence** within a population. *Disease registries for HIV patients* - **Disease registries** are valuable for tracking the natural history, treatment outcomes, and long-term trends among *diagnosed* individuals, but they do not capture undiagnosed cases, thus not accurately representing **prevalence**. - They provide data on incidence (new cases) and patient management but are less suited for estimating the total number of people living with the disease at a given time. *Active case finding through outreach programs* - **Active case finding** aims to identify new cases within specific communities, usually in response to an outbreak or in populations with known high risk. - While it identifies undiagnosed individuals, its primary goal is case identification and linkage to care, rather than providing a **statistically representative prevalence** estimate for an entire population.
Explanation: ***Correct: Measures incidence rate*** - A **case-control study** proceeds from effect (disease) to cause (exposure) and thus does **NOT measure the incidence rate** of a disease. - Case-control studies calculate **odds ratios**, not incidence rates. - **Incidence rate** is typically measured in **cohort studies**, where a group of individuals is followed over time to observe the development of new cases of a disease. *Incorrect: Quick results are obtained* - Case-control studies are generally **retrospective**, meaning they look back in time from the outcome (disease) to identify past exposures. - This design allows for **quicker data collection** and analysis compared to prospective studies like cohort studies, which follow individuals over time. - This IS a characteristic of case-control studies. *Incorrect: Proceeds from effect to cause* - In a case-control study, researchers start by identifying individuals with the **disease (cases)** and a comparable group without the disease (controls). - They then investigate past exposures in both groups to determine potential **risk factors** or causes. - This IS a characteristic of case-control studies. *Incorrect: Inexpensive study* - Case-control studies are typically **less expensive** than other analytical study designs, such as cohort studies. - This is because they do not require long-term follow-up of a large population, reducing costs associated with repeated measurements and participant retention. - This IS a characteristic of case-control studies.
Explanation: ***Randomized controlled trial*** - **Random allocation** minimizes confounding, ensuring that groups are comparable at baseline, which allows for a more definitive assessment of the intervention's effect. - The prospective nature and controlled environment of an RCT enable direct measurement and comparison of outcomes between the intervention and control groups, thereby strengthening the evidence for a **causal relationship**. - RCTs provide the **highest level of evidence** in the hierarchy of study designs for establishing causation. *Case-control study* - This design is **retrospective**, looking back in time to identify exposures after an outcome has occurred, making it prone to **recall bias** regarding past exposures. - While useful for studying rare diseases, it cannot establish temporality unequivocally, which is crucial for inferring causation. *Ecological study* - This study design analyzes data at the **population level** rather than the individual level, making it susceptible to the **ecological fallacy** (attributing group characteristics to individuals). - It cannot directly link exposure to outcome in individuals and is primarily used for generating hypotheses, not establishing causation. *Cross-sectional study* - This design measures exposure and outcome simultaneously at a **single point in time**, which makes it impossible to determine the temporal sequence of events. - Its inability to establish **temporality** means it cannot definitively determine whether the exposure preceded the outcome, a fundamental requirement for causality.
Explanation: ***Arranged in 3 volumes*** - The **ICD-10 classification system** is traditionally published in **three volumes** for ease of use. - **Volume 1** lists diseases alphabetically, **Volume 2** provides instructional and guidelines, and **Volume 3** has an alphanumeric index. *Revised every 10 years* - ICD classifications are revised periodically, but there is **no fixed 10-year revision cycle**; updates occur as needed. - For instance, ICD-9 was in use for many decades before ICD-10 and then ICD-11 was released significantly later. *Consists of 22 chapters* - The ICD-10 classification system is organized into **21 chapters**, each covering a specific range of diseases or health problems. - These chapters categorize diseases and conditions based on criteria such as etiology, body system, or type of injury. *Produced by the World Health Organization* - The **World Health Organization (WHO)** is indeed responsible for developing and maintaining the ICD system. - However, this option describes the **originator** of the system, not its structural arrangement.
Explanation: ***Serial interval*** - This is the **time interval** between the onset of symptoms in a **primary case** and the onset of symptoms in a **secondary case** (an individual infected by the primary case). - It is a crucial measure in **epidemiology** for understanding and modeling disease transmission dynamics. *Generation time* - This refers to the **time interval** between acquiring an infection (primary case) and the moment of transmitting that infection to a **secondary case**. - It can be difficult to measure directly, as the moment of acquiring infection is often unknown. *Incubation period* - This is the **time interval** between exposure to an infectious agent and the **onset of symptoms** in an infected individual. - It describes the time until an individual becomes *ill*, not the interval between cases. *Lead time* - This term is often used in the context of **screening programs** and refers to the time gained by **early diagnosis** through screening compared to diagnosis based on symptoms. - It is not related to the transmission interval between cases.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free